Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Neuro-Oncology"
DOI: 10.1007/s11060-019-03139-6
Abstract: PurposeWe explored the use of intraventricular 131I-Omburtamab targeting B7-H3 in patients with ETMR.MethodsPatients were enrolled in an IRB approved, phase 1, 3 + 3 dose escalation trial. Patients with CNS disease expressing the antibody target antigen B7-H3…
read more here.
Keywords:
131i omburtamab;
omburtamab;
targeted radioimmunotherapy;
patients etmr ... See more keywords